Related Experiment Video
Updated: Jul 26, 2026
08:19
Isolation of Leukocytes from the Human Maternal-fetal Interface
Published on: May 21, 2015
Fetal microchimerisms in the mother: immunologic implications
1Division of Rheumatology, Allergy, and Clinical Immunology, University of California at Davis, 95616-8660, USA.
Summary
Fetal cells can transfer to mothers, causing microchimerism, which may play a role in autoimmune diseases like scleroderma. This fetal cell migration is common and may also aid maternal-fetal tolerance.
Area of Science:
- Reproductive Immunology
- Immunology
- Genetics
Background:
- The placenta was traditionally viewed as a barrier, but recent findings show fetal cells can cross into maternal tissues.
- Fetal cell microchimerism, the presence of fetal cells in mothers, is increasingly recognized.
- The role of microchimerism in maternal health and disease is an emerging area of research.
Purpose of the Study:
- To investigate the presence and implications of fetal cell microchimerism in maternal autoimmune diseases.
- To explore the potential link between fetal cell migration and the pathogenesis of conditions like scleroderma and primary biliary cirrhosis (PBC).
Main Methods:
- Detection of fetal cell-derived DNA in maternal peripheral blood and tissues.
- Comparison of microchimerism frequency in patients with autoimmune diseases versus healthy controls.
Main Results:
- Fetal DNA was found more frequently in the blood of scleroderma patients than controls, suggesting a role in disease induction.
- Microchimerism was common in liver tissues of both PBC patients and controls, indicating it's a frequent event.
- The study suggests microchimerism alone may not fully explain PBC pathogenesis.
Conclusions:
- Fetal cell microchimerism is a common phenomenon with potential roles in both autoimmune disease pathogenesis and maintaining maternal-fetal tolerance during pregnancy.
- While microchimerism may contribute to diseases like scleroderma, its role in PBC appears less direct.
- Further research is needed to fully elucidate the complex interactions between fetal cells and maternal immune systems.
Related Concept Videos
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...